Top Markets
Coin of the day
Baudax Bio, Inc. Baudax Bio, Inc.

Baudax Bio, Inc.

BXRXQ
Classifica tra le azioni #42133
Baudax Bio, Inc., a biotechnology company, develops and commercializes products... Baudax Bio, Inc., a biotechnology company, develops and commercializes products for hospital and other acute care related settings. The company develops T cell receptor, that focus on immune modulating therapies for orphan diseases or complications associated with such diseases, as well as the treatment of autoimmune disorders. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2015 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$4.36K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
9,900.00%
Paese
US
Scambia Baudax Bio, Inc. (BXRXQ)

Categoria

Storico del rendimento da dividendi per Baudax Bio, Inc. (BXRXQ)
Il rendimento da dividendi (TTM) di Baudax Bio, Inc. (simbolo azionario: BXRXQ) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Baudax Bio, Inc. (BXRXQ) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
0.00%
CH
0.65%
BE
0.00%
KR